Literature DB >> 22885046

Identification and quantification of 3-iodothyronamine metabolites in mouse serum using liquid chromatography-tandem mass spectrometry.

Sarah A Hackenmueller1, Thomas S Scanlan.   

Abstract

3-Iodothyronamine (T(1)AM) is an endogenous derivative of thyroxine. Recently there have been numerous reports of analytical methods to quantify endogenous T(1)AM levels, but substantial discrepancies in concentration depending on the method of analysis (LC-MS/MS or immunoassay) suggest endogenous T(1)AM may be covalently modified in vivo. Using information dependent acquisition methods to perform unbiased scans for T(1)AM metabolites following a single IP injection in mice, we have identified O-sulfonate-T(1)AM, N-acetyl-T(1)AM and T(1)AM-glucuronide as conjugates occurring in vivo, as well as the oxidatively deaminated 3-iodothyroacetic acid and non-iodinated thyroacetic acid. 3-iodothyroacetic acid, O-sulfonate-T(1)AM and T(1)AM-glucuronide are present in serum at greater concentrations that unmodified T(1)AM and all metabolites are extensively distributed to tissues. These results suggest covalent modifications of T(1)AM may play a critical role in regulating distribution and biological activity of T(1)AM, and analytical methods to quantify endogenous T(1)AM should be able to account for these metabolites as well.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885046      PMCID: PMC3609710          DOI: 10.1016/j.chroma.2012.07.052

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  15 in total

1.  Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay.

Authors:  Carolin S Hoefig; Josef Köhrle; Georg Brabant; Kashinath Dixit; Beng Yap; Christian J Strasburger; Zida Wu
Journal:  J Clin Endocrinol Metab       Date:  2011-04-13       Impact factor: 5.958

2.  Detection of 3-iodothyronamine in human patients: a preliminary study.

Authors:  Elena Galli; Maja Marchini; Alessandro Saba; Sergio Berti; Massimo Tonacchera; Paolo Vitti; Thomas S Scanlan; Giorgio Iervasi; Riccardo Zucchi
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

3.  Tissue distribution and cardiac metabolism of 3-iodothyronamine.

Authors:  Alessandro Saba; Grazia Chiellini; Sabina Frascarelli; Maja Marchini; Sandra Ghelardoni; Andrea Raffaelli; Massimo Tonacchera; Paolo Vitti; Thomas S Scanlan; Riccardo Zucchi
Journal:  Endocrinology       Date:  2010-08-25       Impact factor: 4.736

4.  Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation.

Authors:  A Hood; C D Klaassen
Journal:  Toxicol Sci       Date:  2000-05       Impact factor: 4.849

5.  Validation of a liquid chromatography-tandem mass spectrometry method to enable quantification of 3-iodothyronamine from serum.

Authors:  Andrea E DeBarber; Travis Geraci; Vincent P Colasurdo; Sarah A Hackenmueller; Thomas S Scanlan
Journal:  J Chromatogr A       Date:  2008-09-12       Impact factor: 4.759

6.  Development of a validated liquid chromatography/tandem mass spectrometry method for the distinction of thyronine and thyronamine constitutional isomers and for the identification of new deiodinase substrates.

Authors:  Susanne Piehl; Thomas Heberer; Gabor Balizs; Thomas S Scanlan; Josef Köhrle
Journal:  Rapid Commun Mass Spectrom       Date:  2008-10       Impact factor: 2.419

7.  3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone.

Authors:  Thomas S Scanlan; Katherine L Suchland; Matthew E Hart; Grazia Chiellini; Yong Huang; Paul J Kruzich; Sabina Frascarelli; Dane A Crossley; James R Bunzow; Simonetta Ronca-Testoni; Emil T Lin; Daniel Hatton; Riccardo Zucchi; David K Grandy
Journal:  Nat Med       Date:  2004-05-16       Impact factor: 53.440

8.  3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation.

Authors:  L J Braulke; M Klingenspor; A DeBarber; S C Tobias; D K Grandy; T S Scanlan; G Heldmaier
Journal:  J Comp Physiol B       Date:  2007-10-03       Impact factor: 2.200

9.  Thyronamines are isozyme-specific substrates of deiodinases.

Authors:  S Piehl; T Heberer; G Balizs; T S Scanlan; R Smits; B Koksch; J Köhrle
Journal:  Endocrinology       Date:  2008-03-13       Impact factor: 4.736

10.  Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo.

Authors:  Warren J L Wood; Travis Geraci; Aaron Nilsen; Andrea E DeBarber; Thomas S Scanlan
Journal:  Chembiochem       Date:  2009-01-26       Impact factor: 3.164

View more
  13 in total

1.  Metabolic study of Angelica dahurica extracts using a reusable liver microsomal nanobioreactor by liquid chromatography-mass spectrometry.

Authors:  Hai-Li Shi; Yan-Wei Jia; Shu-Lin Peng; Xun Liao; Li-Sheng Ding; Yi-Ming Liu
Journal:  Biomed Chromatogr       Date:  2015-03-08       Impact factor: 1.902

2.  3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male diet-induced obese mice.

Authors:  Wenke Jonas; Julika Lietzow; Franziska Wohlgemuth; Carolin S Hoefig; Petra Wiedmer; Ulrich Schweizer; Josef Köhrle; Annette Schürmann
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

3.  3-Iodothyroacetic acid lacks thermoregulatory and cardiovascular effects in vivo.

Authors:  Carolin S Hoefig; Simon F Jacobi; Amy Warner; Lisbeth Harder; Nancy Schanze; Björn Vennström; Jens Mittag
Journal:  Br J Pharmacol       Date:  2015-06-09       Impact factor: 8.739

4.  Quantitative Analysis of Thyroid Hormone Metabolites in Cell Culture Samples Using LC-MS/MS.

Authors:  Daniel Rathmann; Eddy Rijntjes; Julika Lietzow; Josef Köhrle
Journal:  Eur Thyroid J       Date:  2015-05-28

Review 5.  Tissue thyroid hormones and thyronamines.

Authors:  Alice Accorroni; Federica Saponaro; Riccardo Zucchi
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

Review 6.  Thyroid hormone regulation of metabolism.

Authors:  Rashmi Mullur; Yan-Yun Liu; Gregory A Brent
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

7.  Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism.

Authors:  Claudia Musilli; Gaetano De Siena; Maria Elena Manni; Andrea Logli; Elisa Landucci; Riccardo Zucchi; Alessandro Saba; Riccardo Donzelli; Maria Beatrice Passani; Gustavo Provensi; Laura Raimondi
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

8.  N- and O-Acetylated 3-Iodothyronamines Have No Metabolic or Thermogenic Effects in Male Mice.

Authors:  Sogol Gachkar; Rebecca Oelkrug; Beate Herrmann; Thomas S Scanlan; Qian Sun; Heike Biebermann; Carolin S Hoefig; Lutz Schomburg; Jens Mittag
Journal:  Eur Thyroid J       Date:  2019-12-20

9.  In vivo Effects of Repeated Thyronamine Administration in Male C57BL/6J Mice.

Authors:  Lisbeth Harder; Nancy Schanze; Assel Sarsenbayeva; Franziska Kugel; Josef Köhrle; Lutz Schomburg; Jens Mittag; Carolin S Hoefig
Journal:  Eur Thyroid J       Date:  2017-12-05

10.  Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5.

Authors:  Juliane Dinter; Jessica Mühlhaus; Carolin Leonie Wienchol; Chun-Xia Yi; Daniela Nürnberg; Silke Morin; Annette Grüters; Josef Köhrle; Torsten Schöneberg; Matthias Tschöp; Heiko Krude; Gunnar Kleinau; Heike Biebermann
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.